AAAAAA
Results:
1-16
|
Results: 16
Authors:
Schutz, J
Krassnig, R
Schmidhammer, H
Wurst, W
Lattanzi, R
Negri, L
Citation: J. Schutz et al., Synthesis and pharmacological evaluation of 18,19-dehydrobuprenorphine, HETEROCYCLE, 54(2), 2001, pp. 989
Authors:
Spetea, M
Harris, HE
Berzetei-Gurske, IP
Klareskog, L
Schmidhammer, H
Citation: M. Spetea et al., Binding, pharmacological and immunological profiles of the delta-selectiveopioid receptor antagonist HS 378, LIFE SCI, 69(15), 2001, pp. 1775-1782
Authors:
Biyashev, D
Monory, K
Benyhe, S
Schutz, J
Koch, M
Schmidhammer, H
Borsodi, A
Citation: D. Biyashev et al., Novel delta-opioid-receptor-selective ligands in the 14-alkoxy-substitutedindolo- and benzofuromorphinan series, HELV CHIM A, 84(7), 2001, pp. 2015-2021
Authors:
Lattanzi, R
Negri, L
Giannini, E
Schmidhammer, H
Schutz, J
Improta, G
Citation: R. Lattanzi et al., HS-599: a novel long acting opioid analgesic does not induce place-preference in rats, BR J PHARM, 134(2), 2001, pp. 441-447
Authors:
Greiner, E
Schottenberger, H
Wurst, K
Schmidhammer, H
Citation: E. Greiner et al., Novel class of morphinans with acrylonitrile incorporated substructures askey intermediates for non-oxygen-bridged opioid ligands, J AM CHEM S, 123(16), 2001, pp. 3840-3841
Authors:
Zernig, G
Saria, A
Krassnig, R
Schmidhammer, H
Citation: G. Zernig et al., Signal transduction efficacy of the highly potent mu opioid agonist 14-methoxymetopon, LIFE SCI, 66(19), 2000, pp. 1871-1877
Authors:
Krassnig, R
Schmidhammer, H
Wurst, K
Citation: R. Krassnig et al., A novel method for the introduction of a 5 beta-methyl group into 4,5 alpha-epoxymorphinan-6-ones via the enol ether, HELV CHIM A, 83(2), 2000, pp. 380-383
Authors:
Labarre, M
Butterworth, J
St-Onge, S
Payza, K
Schmidhammer, H
Salvadori, S
Balboni, G
Guerrini, R
Bryant, SD
Lazarus, LH
Citation: M. Labarre et al., Inverse agonism by Dmt-Tic analogues and H5 378, a naltrindole analogue, EUR J PHARM, 406(1), 2000, pp. R1-R3
Authors:
Freye, E
Schmidhammer, H
Latasch, L
Citation: E. Freye et al., 14-methoxymetopon, a potent opioid, induces no respiratory depression, less sedation, and less bradycardia than sufentanil in the dog, ANESTH ANAL, 90(6), 2000, pp. 1359-1364
Authors:
Moiseev, SK
Bakhanova, IV
Schmidhammer, H
Kalinin, VN
Citation: Sk. Moiseev et al., Synthesis of N-phenyl-substituted derivatives of morphine alkaloids, RUSS CHEM B, 48(3), 1999, pp. 589-592
Authors:
Monory, K
Greiner, E
Sartania, N
Sallai, L
Pouille, Y
Schmidhammer, H
Hanoune, J
Borsodi, A
Citation: K. Monory et al., Opioid binding profiles of new hydrazone, oxime, carbazone and semicarbazone derivatives of 14-alkoxymorphinans, LIFE SCI, 64(22), 1999, pp. 2011-2020
Authors:
Marki, A
Monory, K
Otvos, F
Toth, G
Krassnig, R
Schmidhammer, H
Traynor, JR
Roques, BP
Maldonado, R
Borsodi, A
Citation: A. Marki et al., mu-Opioid receptor specific antagonist cyprodime: characterization by in vitro radioligand and [S-35]GTP gamma S binding assays, EUR J PHARM, 383(2), 1999, pp. 209-214
Authors:
Hutcheson, DM
Sanchez-Blazquez, P
Rodriguez-Diaz, M
Garzon, J
Schmidhammer, H
Borsodi, A
Roques, BP
Maldonado, R
Citation: Dm. Hutcheson et al., Use of selective antagonists and antisense oligonucleotides to evaluate the mechanisms of BUBU antinociception, EUR J PHARM, 383(1), 1999, pp. 29-37
Authors:
Bakhanova, IV
Nesterov, VN
Moiseev, SK
Schmidhammer, H
Kalinin, VN
Citation: Iv. Bakhanova et al., Molecular and crystal structures of (6R,7R,14S)-6,14-etheno-7-[(1R)-1-hydroxyethyl]- and (6R,7R,14S)-6,14-etheno-7-[(1S)-1-hydroxyethyl]-6,7,8,14-tetrahydro-17-nor-17-phenylthebaine, RUSS CHEM B, 47(11), 1998, pp. 2177-2181
Authors:
Schmidhammer, H
Krassnig, R
Greiner, E
Traynor, JR
Citation: H. Schmidhammer et al., Synthesis and biological evaluation of 14-alkoxymorphinans. 16. 14-O-alkylderivatives of the mu opioid receptor antagonist cyprodime, HETEROCYCLE, 49, 1998, pp. 489-497
Authors:
Schmidhammer, H
Citation: H. Schmidhammer, Opioid receptor antagonists, PROG MED CH, 35, 1998, pp. 83-132
Risultati:
1-16
|